Exploring therapeutic strategies for infantile neuronal axonal dystrophy (INAD/PARK14)

Overview of attention for article published in eLife, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog

twitter: 9 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 186,938 followers.

RT @interactivefly: Lin, G., Tepe, B., McGrane, G., Tipon, R., Croft, G., Panwala, L., Hope, A., Liang, A., Zuo, Z., Byeon, S. K., Wang, L.…

Lin, G., Tepe, B., McGrane, G., Tipon, R., Croft, G., Panwala, L., Hope, A., Liang, A., Zuo, Z., Byeon, S. K., Wang, L., Pandey, A. and Bellen, H. J. (2023). Exploring therapeutic strategies for infantile neuronal axonal dystrophy (INAD/PARK14) . Elife …

RT @medical_xpress: Scientists discover biomarkers and therapies for a group of fatal pediatric neurodegenerative disorders @elife https://…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.